- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.4: 11 residues within 4Å:- Chain A: E.181, P.182, V.224, L.231, N.232, N.346, C.347, G.348, V.414, S.415
- Ligands: NAG.36
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.348
NAG-NAG-BMA-MAN.14: 12 residues within 4Å:- Chain C: S.179, E.181, P.182, V.224, L.231, N.232, N.346, G.348, C.413, V.414, S.415
- Ligands: NAG-NAG.22
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.181, C:S.179
NAG-NAG-BMA-MAN.29: 8 residues within 4Å:- Chain E: Q.1, Y.33, E.105
- Chain F: Q.100, S.120, F.121, N.122, K.133
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:Q.1, E:Y.33
NAG-NAG-BMA-MAN.30: 5 residues within 4Å:- Chain F: N.106, N.118, Y.135, L.137, D.290
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.7: 5 residues within 4Å:- Chain A: Q.100, S.120, F.121, N.122, K.133
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 11 residues within 4Å:- Chain F: E.181, P.182, V.224, L.231, N.232, N.346, C.347, G.348, V.414, S.415
- Ligands: NAG.52
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:G.348, F:V.414
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.16: 14 residues within 4Å:- Chain C: T.98, Q.100, S.120, F.121, N.122
- Chain E: Y.104, D.106, Y.112, Y.117
- Chain H: S.33, H.51, N.52, G.53, Q.54
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain H- Hydrophobic interactions: E:Y.117, H:H.51
- Hydrogen bonds: H:N.52, H:Q.54, H:Q.54
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.17: 12 residues within 4Å:- Chain C: V.104, N.118, Y.135, L.137, G.289, D.290
- Chain E: N.60, K.66
- Chain H: S.27, D.94, M.95, N.97
4 PLIP interactions:1 interactions with chain H, 1 interactions with chain C, 2 interactions with chain E- Hydrogen bonds: H:D.94, C:D.290, E:N.60, E:N.60
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.36: 4 residues within 4Å:- Chain A: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN.4
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain A: N.103, K.117, R.140
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain A: E.57, N.58
- Chain B: S.16
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: N.308, W.364
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain A: N.271, I.292, V.410
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain A: N.204, T.206, S.244
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain A: N.246, T.248
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain A: N.106, N.107, G.293
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain B: K.121, E.122, S.124, N.125
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain C: N.246, T.248, N.249
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain C: N.324
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.103
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: N.308, L.311, S.362, W.364
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain C: N.107
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain D: N.99, S.101, W.102
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain D: K.121, E.122, N.125, Y.126
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain F: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA.27
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain F: N.246, T.248, N.249
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain F: N.324
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain F: E.57, N.58
- Chain G: S.16
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain F: N.308
Ligand excluded by PLIPNAG.57: 2 residues within 4Å:- Chain F: N.107, D.294
Ligand excluded by PLIPNAG.58: 4 residues within 4Å:- Chain G: N.104, N.106, S.108, E.109
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain G: K.121, E.122, N.125
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roark, R.S. et al., Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. J.Exp.Med. (2025)


- Release Date
- 2025-05-21
- Peptides
- Envelope glycoprotein Gp120: ACF
Envelope glycoprotein Gp41: BDG
41328-a.01 heavy chain: E
41328-a.01 light chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
EF
IB
BD
FG
JE
HH
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roark, R.S. et al., Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. J.Exp.Med. (2025)


- Release Date
- 2025-05-21
- Peptides
- Envelope glycoprotein Gp120: ACF
Envelope glycoprotein Gp41: BDG
41328-a.01 heavy chain: E
41328-a.01 light chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
EF
IB
BD
FG
JE
HH
L